The purpose of this study is to evaluate the incidence and evolution over-time of co-morbidities in a general dual-chamber pacemaker population (n=2188 patients) through a 2 years follow-up.
The study will focus on the number of patients moving to persistent Atrial Fibrillation as a function of cumulative %Vp (\< or \>40%), in a general dual-chamber pacemaker population through a 2 year follow-up (n=2188). The same endpoint will be analyzed in sub populations (Sinus Node Disease and AVB) at 4 years follow up (n=4290).
Study Type
OBSERVATIONAL
Enrollment
4,350
Atrial arrhythmias incidence
Two consecutive visits in which atrial fibrillation was present or - at least 22 hours of atrial fibrillation for at least 7 consecutive days or - at least 22 hours of atrial fibrillation per day for fewer than 7 consecutive days if an interruption by electrical or pharmacologic cardioversion occurred
Time frame: 2 years
% ventricular pacing
as measured in the device over the timeframe period
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Southwest Cardiovascular Associates
Mesa, Arizona, United States
Mountain Vista Medical Center
Mesa, Arizona, United States
Pacific Arrhythmia Services
Mesa, Arizona, United States
Unnamed facility
Peoria, Arizona, United States
Advanced Heart and Vascular Institute
Phoenix, Arizona, United States
Harishchandra N. Patel, M.D., Inc.
Anaheim, California, United States
Narayan R. Devaraj, M.D., Inc.
Anaheim, California, United States
St. Rose Hospital
Fremont, California, United States
Unnamed facility
Hanford, California, United States
Unnamed facility
Los Angeles, California, United States
...and 180 more locations